n-(2-hydroxypropyl)methacrylamide has been researched along with Heart Failure in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellini, O; Duncan, R; Grandi, M; Hopewell, JW; Seymour, LW; Simmonds, RH; Spreafico, F; Strohalm, J; Ulbrich, K; Yeung, TK | 1 |
1 other study(ies) available for n-(2-hydroxypropyl)methacrylamide and Heart Failure
| Article | Year |
|---|---|
Reduced cardiotoxicity of doxorubicin given in the form of N-(2-hydroxypropyl)methacrylamide conjugates: and experimental study in the rat.
Topics: Acrylamides; Animals; Body Weight; Doxorubicin; Drug Combinations; Drug Evaluation, Preclinical; Heart; Heart Failure; Heart Rate; Male; Rats; Rats, Inbred Strains | 1991 |